Selected research
Industry Research
Vaccine Microneedle Patches Industry Research Report 2026
Market perspective
The global Vaccine Microneedle Patches market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Vaccine Microneedle Patches is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Vaccine Microneedle Patches is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Vaccine Microneedle Patches include CosMED Pharmaceutical, Micron Biomedical, Raphas, VaxessTechnologies, Shenzhen Qinglan Biotechnology, WCC Biomedical and Zhuhai Youwe Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Vaccine Microneedle Patches market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vaccine Microneedle Patches Market by Company
CosMED Pharmaceutical
Micron Biomedical
Raphas
VaxessTechnologies
Shenzhen Qinglan Biotechnology
WCC Biomedical
Zhuhai Youwe Biotechnology
Vaccine Microneedle Patches Segment by Type
Polymers Material
Silicon Material
Others
Vaccine Microneedle Patches Segment by Application
COVID-19 Vaccine
Enterovirus 71 Vaccine
Other Vaccines
Vaccine Microneedle Patches Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Microneedle Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Microneedle Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Microneedle Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vaccine Microneedle Patches manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vaccine Microneedle Patches by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vaccine Microneedle Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polymers Material
- Silicon Material
- Others
Applications
- COVID-19 Vaccine
- Enterovirus 71 Vaccine
- Other Vaccines
Companies covered
- CosMED Pharmaceutical
- Micron Biomedical
- Raphas
- VaxessTechnologies
- Shenzhen Qinglan Biotechnology
- WCC Biomedical
- Zhuhai Youwe Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Vaccine Microneedle Patches Market Size (2021-2032)
- 2.2.2 Global Vaccine Microneedle Patches Sales (2021-2032)
- 2.2.3 Global Vaccine Microneedle Patches Market Average Price (2021-2032)
- 2.3 Vaccine Microneedle Patches by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polymers Material
- 2.3.3 Silicon Material
- 2.3.4 Others
- 2.4 Vaccine Microneedle Patches by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 COVID-19 Vaccine
- 2.4.3 Enterovirus 71 Vaccine
- 2.4.4 Other Vaccines
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vaccine Microneedle Patches Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Vaccine Microneedle Patches Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Vaccine Microneedle Patches Revenue of Manufacturers (2021-2026)
- 3.4 Global Vaccine Microneedle Patches Average Price by Manufacturers (2021-2026)
- 3.5 Global Vaccine Microneedle Patches Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Vaccine Microneedle Patches, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Vaccine Microneedle Patches, Product Type & Application
- 3.8 Global Manufacturers of Vaccine Microneedle Patches, Established Date
- 3.9 Global Vaccine Microneedle Patches Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CosMED Pharmaceutical
- 4.1.1 CosMED Pharmaceutical Company Information
- 4.1.2 CosMED Pharmaceutical Business Overview
- 4.1.3 CosMED Pharmaceutical Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CosMED Pharmaceutical Vaccine Microneedle Patches Product Portfolio
- 4.1.5 CosMED Pharmaceutical Recent Developments
- 4.2 Micron Biomedical
- 4.2.1 Micron Biomedical Company Information
- 4.2.2 Micron Biomedical Business Overview
- 4.2.3 Micron Biomedical Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Micron Biomedical Vaccine Microneedle Patches Product Portfolio
- 4.2.5 Micron Biomedical Recent Developments
- 4.3 Raphas
- 4.3.1 Raphas Company Information
- 4.3.2 Raphas Business Overview
- 4.3.3 Raphas Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Raphas Vaccine Microneedle Patches Product Portfolio
- 4.3.5 Raphas Recent Developments
- 4.4 VaxessTechnologies
- 4.4.1 VaxessTechnologies Company Information
- 4.4.2 VaxessTechnologies Business Overview
- 4.4.3 VaxessTechnologies Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 VaxessTechnologies Vaccine Microneedle Patches Product Portfolio
- 4.4.5 VaxessTechnologies Recent Developments
- 4.5 Shenzhen Qinglan Biotechnology
- 4.5.1 Shenzhen Qinglan Biotechnology Company Information
- 4.5.2 Shenzhen Qinglan Biotechnology Business Overview
- 4.5.3 Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Product Portfolio
- 4.5.5 Shenzhen Qinglan Biotechnology Recent Developments
- 4.6 WCC Biomedical
- 4.6.1 WCC Biomedical Company Information
- 4.6.2 WCC Biomedical Business Overview
- 4.6.3 WCC Biomedical Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 WCC Biomedical Vaccine Microneedle Patches Product Portfolio
- 4.6.5 WCC Biomedical Recent Developments
- 4.7 Zhuhai Youwe Biotechnology
- 4.7.1 Zhuhai Youwe Biotechnology Company Information
- 4.7.2 Zhuhai Youwe Biotechnology Business Overview
- 4.7.3 Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Product Portfolio
- 4.7.5 Zhuhai Youwe Biotechnology Recent Developments
5 Global Vaccine Microneedle Patches Market Scenario by Region
- 5.1 Global Vaccine Microneedle Patches Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vaccine Microneedle Patches Sales by Region: 2021-2032
- 5.2.1 Global Vaccine Microneedle Patches Sales by Region: 2021-2026
- 5.2.2 Global Vaccine Microneedle Patches Sales by Region: 2027-2032
- 5.3 Global Vaccine Microneedle Patches Revenue by Region: 2021-2032
- 5.3.1 Global Vaccine Microneedle Patches Revenue by Region: 2021-2026
- 5.3.2 Global Vaccine Microneedle Patches Revenue by Region: 2027-2032
- 5.4 North America Vaccine Microneedle Patches Market Facts & Figures by Country
- 5.4.1 North America Vaccine Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Vaccine Microneedle Patches Sales by Country (2021-2032)
- 5.4.3 North America Vaccine Microneedle Patches Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Vaccine Microneedle Patches Market Facts & Figures by Country
- 5.5.1 Europe Vaccine Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Vaccine Microneedle Patches Sales by Country (2021-2032)
- 5.5.3 Europe Vaccine Microneedle Patches Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Vaccine Microneedle Patches Market Facts & Figures by Country
- 5.6.1 Asia Pacific Vaccine Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Vaccine Microneedle Patches Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Vaccine Microneedle Patches Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Vaccine Microneedle Patches Market Facts & Figures by Country
- 5.7.1 South America Vaccine Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Vaccine Microneedle Patches Sales by Country (2021-2032)
- 5.7.3 South America Vaccine Microneedle Patches Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Vaccine Microneedle Patches Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Vaccine Microneedle Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Vaccine Microneedle Patches Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Vaccine Microneedle Patches Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Vaccine Microneedle Patches Sales by Type (2021-2032)
- 6.1.1 Global Vaccine Microneedle Patches Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Vaccine Microneedle Patches Sales Market Share by Type (2021-2032)
- 6.2 Global Vaccine Microneedle Patches Revenue by Type (2021-2032)
- 6.2.1 Global Vaccine Microneedle Patches Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Vaccine Microneedle Patches Revenue Market Share by Type (2021-2032)
- 6.3 Global Vaccine Microneedle Patches Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Vaccine Microneedle Patches Sales by Application (2021-2032)
- 7.1.1 Global Vaccine Microneedle Patches Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Vaccine Microneedle Patches Sales Market Share by Application (2021-2032)
- 7.2 Global Vaccine Microneedle Patches Revenue by Application (2021-2032)
- 7.2.1 Global Vaccine Microneedle Patches Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Vaccine Microneedle Patches Revenue Market Share by Application (2021-2032)
- 7.3 Global Vaccine Microneedle Patches Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Vaccine Microneedle Patches Value Chain Analysis
- 8.1.1 Vaccine Microneedle Patches Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Vaccine Microneedle Patches Production Mode & Process
- 8.2 Vaccine Microneedle Patches Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Vaccine Microneedle Patches Distributors
- 8.2.3 Vaccine Microneedle Patches Customers
9 Global Vaccine Microneedle Patches Analyzing Market Dynamics
- 9.1 Vaccine Microneedle Patches Industry Trends
- 9.2 Vaccine Microneedle Patches Industry Drivers
- 9.3 Vaccine Microneedle Patches Industry Opportunities and Challenges
- 9.4 Vaccine Microneedle Patches Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst